Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.
Read MoreInsights
Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.
Read MoreInsights
A new study by Global Good and its partners explores how reinventing two common household items—the window and door—could save lives by keeping pesky mosquitoes out of African homes.
Read MoreInsights
In a new study published in the journal Icarus, Nathan argues that astronomers don’t have as good a handle on the size and other physical characteristics of asteroids as they previously thought.
Read MoreInsights
The World Health Organization-approved eLearning tool can be used regardless of Internet access.
Read MorePress Releases
New, high-impact detection kit will prove useful for both P. falciparum and P. vivax species.
Read MorePress Releases
“With this license, we are one step closer to ending the unlicensed use of our technology by the insurance industry,” said Mathen Ganesan, executive vice president, Invention Investment Fund at Intellectual Ventures.
Read MorePress Releases
Algorithm could revolutionize cervical cancer screening, especially in low-resource settings.
Read MorePress Releases
Microbiologists now have ability to adequately conduct microbiological tests in laboratories with unreliable access to power.
Read MorePublications
With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.
Read MorePublications
Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.
Read MorePublications
Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.
Read MorePublications
Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.
Read MoreMedia Coverage
GeekWire
EarthNow announced exciting new updates in its mission to establish high-res, real time video from space. The IV spinout hopes to launch its first satellite by 2020.
Read MoreMedia Coverage
Harvard Business Review
IV co-founder Edward Jung was in Harvard Business Review for contributing a piece on Local Innovation Bonds and different ways to invest in tech startups.
Read MoreMedia Coverage
Puget Sound Business Journal
Tony Pan, co-founder and CEO of IV spinout Modern Electron, was named Puget Sound Business Journal’s Innovator of the Month this December.
Read MoreMedia Coverage
The Seattle Times
IV research scientist Corrie Ortega shares her background and what her experience at IV has been like in this Seattle Times Q&A.
Read More